Plasmapheresis & Intravenous Immunoglobin
Clinical Uses, Potential Complications & Long-Term Health Effects
Seiten
2014
Nova Science Publishers Inc (Verlag)
978-1-63117-916-7 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-63117-916-7 (ISBN)
Plasmapheresis is a therapeutic tool used to treat a wide range of disease processes, and in which the priority aim is to ensure sufficient plasma exchange to reduce or eliminate symptoms resulting from the action of pathogenic elements vehiculised in the plasma. Scientific selective apheresis with principles of evidence-based medicine involves the application of one of the oldest therapeutic modalities (bleeding), widely used between the fourth century B.C. and the second industrial revolution. This book provides information on the use of plasmapheresis during pregnancy; therapeutic use of autologous plasma for the treatment of dry eye disease; and therapeutic plasma exchange in the neurological setting. It also discusses intravenous immunoglobulins. During the past decades intravenous immunoglobulins (IVIG) have gained more and more popularity for the treatment of a wide range of diseases and conditions. This treatment is extensively used in immune deficits, autoimmune thrombocytopenia, Kawasaki's disease, for the prevention of infectious complications due to hypogammaglobulinaemia secondary to myeloma, chronic lymphatic leukaemia and post-bone marrow and stem cell transplantation, in Guillain-Barre syndrome, etc. IV-Ig is obtained from the plasma of healthy blood donors and contains normal, polyclonal, polyspecific immunoglobins (Ig), mostly consisting of intact IgG. These antibodies are directed against non-self-antigens, self-antigens (natural autoantibodies), and other antibodies (idiotypic antibodies). The administration of intravenous immunoglobulin (IVIG) is generally safe and well tolerated. However, the treatment of autoimmune disorders usually requires high dose therapy (1-2 g/kg) that may result in a greater frequency of side effects and adverse events. This book discusses several topics including the clinical application of intravenous immunoglobulins in autoimmune mediated ocular inflammatory diseases; complications of intravenous immunoglobulin therapy; clinical uses; and side effects.
Clinical Application of Intravenous Immunoglobulins in Autoimmune Mediated Ocular Inflammatory Diseases; Complications of Intravenous Immunoglobulin Therapy; Use of Plasma Replacement Therapy during Pregnancy; Effects of IVIg on T Cell Functions; Intravenous Immunoglobin (IVIG): Clinical Uses in Autoimmune Disorders As Especially Eosinophilic Granulomatosis with Polyangiitis, Potential Complications & Long-Term Efficacy; Therapy with Immunoglobulin in Patients with Acute Myocarditis; Therapeutic Use of Autologous Plasma for the Treatment of Dry Eye Disease; Side Effects of Intravenous Immunoglobulins (IVIG); Therapeutic Plasma Exchange in the Neurological Setting: Some Special Cases.
Verlagsort | New York |
---|---|
Sprache | englisch |
Maße | 155 x 230 mm |
Gewicht | 484 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
ISBN-10 | 1-63117-916-0 / 1631179160 |
ISBN-13 | 978-1-63117-916-7 / 9781631179167 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Hämatologie und Internistische Onkologie
Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
CHF 179,95
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 73,00